HEADER TRANSFERASE 04-NOV-04 1WBP TITLE SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE SPRK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 42-256 AND 474-655; COMPND 5 SYNONYM: SRPK1, SRPK1A PROTEIN KINASE, SERINE/ARGININE- RICH PROTEIN COMPND 6 SPECIFIC KINASE 1, SR-PROTEIN-SPECIFIC KINASE 1, SFRS PROTEIN KINASE COMPND 7 1; COMPND 8 EC: 2.7.1.37; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAIN- COMPND 12 CONTAINING PROTEIN 1; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: RESIDUES 1382-1390; COMPND 15 SYNONYM: ATROPHIN-1-INTERACTING PROTEIN 3,AIP-3,BAI1-ASSOCIATED COMPND 16 PROTEIN 1,BAP-1,MEMBRANE-ASSOCIATED GUANYLATE KINASE INVERTED 1,MAGI- COMPND 17 1,TRINUCLEOTIDE REPEAT-CONTAINING GENE 19 PROTEIN, WW DOMAIN- COMPND 18 CONTAINING PROTEIN 3,WWP3,9-MER PEPTIDE; COMPND 19 ENGINEERED: YES; COMPND 20 OTHER_DETAILS: 9 MER PEPTIDE RRRERSPTR BOUND TO A GROOVE FORMED BY COMPND 21 THE MAP KINASE INSERT, HELIX AF AND HELIX AG SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET15B; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS SRPK, KINASE, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ATP- KEYWDS 2 BINDING, CHROMOSOME PARTITION, DIFFERENTIATION, MRNA PROCESSING, KEYWDS 3 MRNA SPLICING, NUCLEAR PROTEIN, NUCLEOTIDE-BINDING, PHOSPHORYLATION EXPDTA X-RAY DIFFRACTION AUTHOR J.C.NGO,J.GULLINSGRUD,S.CHAKRABARTI,B.NOLEN,B.E.AUBOL,X.-D.FU, AUTHOR 2 J.A.ADAMS,J.A.MCCAMMON,G.GHOSH REVDAT 4 13-DEC-23 1WBP 1 REMARK REVDAT 3 08-FEB-17 1WBP 1 COMPND SOURCE KEYWDS AUTHOR REVDAT 3 2 1 JRNL REMARK VERSN DBREF REVDAT 3 3 1 MASTER REVDAT 2 24-FEB-09 1WBP 1 VERSN REVDAT 1 19-OCT-05 1WBP 0 JRNL AUTH J.C.NGO,S.CHAKRABARTI,J.-H.DING,A.VELAZQUEZ-DONES,B.NOLEN, JRNL AUTH 2 B.E.AUBOL,J.A.ADAMS,X.-D.FU,G.GHOSH JRNL TITL INTERPLAY BETWEEN SRPK AND CLK/STY KINASES IN JRNL TITL 2 PHOSPHORYLATION OF THE SPLICING FACTOR ASF/SF2 IS REGULATED JRNL TITL 3 BY A DOCKING MOTIF IN ASF/SF2 JRNL REF MOL.CELL V. 20 77 2005 JRNL REFN ISSN 1097-2765 JRNL PMID 16209947 JRNL DOI 10.1016/J.MOLCEL.2005.08.025 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 384267.630 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 67.1 REMARK 3 NUMBER OF REFLECTIONS : 15613 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 476 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 27.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1037 REMARK 3 BIN R VALUE (WORKING SET) : 0.4780 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2910 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 96.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 21.30000 REMARK 3 B22 (A**2) : 21.30000 REMARK 3 B33 (A**2) : -42.61000 REMARK 3 B12 (A**2) : 14.59000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM SIGMAA (A) : 0.81 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.53 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.75 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 8.480 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 11.440; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 8.260 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 10.700; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 51.72 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ALL.PAR REMARK 3 PARAMETER FILE 4 : ACETATE.PAR REMARK 3 PARAMETER FILE 5 : ADP.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ALL.TOP REMARK 3 TOPOLOGY FILE 4 : ACETATE.TOP REMARK 3 TOPOLOGY FILE 5 : ADP.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WBP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1290021510. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 105.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22765 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 11.00 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1WAK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM CITRATE PH5.6, 200MM REMARK 280 AMMONIUM ACETATE, 15%PEG3350, 5MM PEPTIDE, 5MM ADP, 10MM MGCL2, REMARK 280 PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 207.02667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 103.51333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 155.27000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 51.75667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 258.78333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 207.02667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 103.51333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 51.75667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 155.27000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 258.78333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE PROTEIN IS A MONOMER IN SOLUTION, BUT REMARK 300 SINCEIN THIS ENTRY, IT IS COMPLEX WITH A REMARK 300 PEPTIDE, THEENTRY IS BEING MARKED AS DIMERIC.FOR REMARK 300 THE HETERO-ASSEMBLY DESCRIBED BY REMARK 350 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 INVOLVED IN THE REGULATORY NETWORK FOR SPLICING, CONTROLLING REMARK 400 THE INTRANUCLEAR DISTRIBUTION OF SPLICING FACTORS IN REMARK 400 INTERPHASE CELLS AND THE REORGANIZATION OF NUCLEAR SPECKLES REMARK 400 DURING MITOSIS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 42 REMARK 465 GLU A 43 REMARK 465 GLN A 44 REMARK 465 GLU A 45 REMARK 465 GLU A 46 REMARK 465 GLU A 47 REMARK 465 ILE A 48 REMARK 465 LEU A 49 REMARK 465 GLY A 50 REMARK 465 SER A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 ASP A 54 REMARK 465 GLU A 55 REMARK 465 GLN A 56 REMARK 465 GLU A 57 REMARK 465 ASP A 58 REMARK 465 PRO A 59 REMARK 465 ASN A 60 REMARK 465 ASP A 61 REMARK 465 TYR A 62 REMARK 465 CYS A 63 REMARK 465 LYS A 64 REMARK 465 GLY A 65 REMARK 465 GLY A 66 REMARK 465 TRP A 238 REMARK 465 GLN A 239 REMARK 465 ARG A 240 REMARK 465 SER A 241 REMARK 465 GLY A 242 REMARK 465 ALA A 243 REMARK 465 PRO A 244 REMARK 465 PRO A 245 REMARK 465 PRO A 246 REMARK 465 SER A 247 REMARK 465 GLY A 248 REMARK 465 SER A 249 REMARK 465 ALA A 250 REMARK 465 VAL A 251 REMARK 465 SER A 252 REMARK 465 THR A 253 REMARK 465 ALA A 254 REMARK 465 PRO A 255 REMARK 465 ALA A 256 REMARK 465 THR A 474 REMARK 465 ALA A 475 REMARK 465 GLY A 476 REMARK 465 ARG B 1 REMARK 465 ARG B 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A 155 C VAL A 156 N -0.194 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 68 75.63 174.43 REMARK 500 ARG A 79 -17.64 -158.42 REMARK 500 LYS A 103 49.10 23.31 REMARK 500 ALA A 114 145.78 -33.29 REMARK 500 SER A 134 -33.25 -31.01 REMARK 500 ASP A 135 91.52 178.49 REMARK 500 PHE A 151 -175.69 -177.56 REMARK 500 ASN A 157 -108.82 -62.61 REMARK 500 SER A 179 0.59 -64.36 REMARK 500 THR A 205 -73.60 -85.17 REMARK 500 THR A 212 -4.85 61.64 REMARK 500 ASP A 213 72.28 -153.35 REMARK 500 THR A 236 116.66 -20.04 REMARK 500 LEU A 479 -155.03 -122.12 REMARK 500 PRO A 485 -7.97 -56.34 REMARK 500 LEU A 491 136.28 -31.00 REMARK 500 ASP A 497 73.12 55.57 REMARK 500 GLN A 513 133.49 64.87 REMARK 500 ARG A 515 -79.02 -25.96 REMARK 500 GLN A 516 -19.96 -48.40 REMARK 500 LYS A 575 146.21 -28.17 REMARK 500 LYS A 588 -15.14 -49.42 REMARK 500 GLU B 4 -168.92 47.97 REMARK 500 SER B 6 108.50 -36.56 REMARK 500 THR B 8 137.82 178.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 950 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WAK RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF SRPK1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 PROTEIN SEQUENCE FROM NCBI (PROTEIN) ACCESSION NP_003128 DBREF 1WBP A 42 256 UNP Q12890 SRPK1_HUMAN 42 256 DBREF 1WBP A 474 655 UNP Q12890 SRPK1_HUMAN 474 655 DBREF 1WBP B 1 9 UNP Q96QZ7 MAGI1_HUMAN 1382 1390 SEQRES 1 A 397 PRO GLU GLN GLU GLU GLU ILE LEU GLY SER ASP ASP ASP SEQRES 2 A 397 GLU GLN GLU ASP PRO ASN ASP TYR CYS LYS GLY GLY TYR SEQRES 3 A 397 HIS LEU VAL LYS ILE GLY ASP LEU PHE ASN GLY ARG TYR SEQRES 4 A 397 HIS VAL ILE ARG LYS LEU GLY TRP GLY HIS PHE SER THR SEQRES 5 A 397 VAL TRP LEU SER TRP ASP ILE GLN GLY LYS LYS PHE VAL SEQRES 6 A 397 ALA MET LYS VAL VAL LYS SER ALA GLU HIS TYR THR GLU SEQRES 7 A 397 THR ALA LEU ASP GLU ILE ARG LEU LEU LYS SER VAL ARG SEQRES 8 A 397 ASN SER ASP PRO ASN ASP PRO ASN ARG GLU MET VAL VAL SEQRES 9 A 397 GLN LEU LEU ASP ASP PHE LYS ILE SER GLY VAL ASN GLY SEQRES 10 A 397 THR HIS ILE CYS MET VAL PHE GLU VAL LEU GLY HIS HIS SEQRES 11 A 397 LEU LEU LYS TRP ILE ILE LYS SER ASN TYR GLN GLY LEU SEQRES 12 A 397 PRO LEU PRO CYS VAL LYS LYS ILE ILE GLN GLN VAL LEU SEQRES 13 A 397 GLN GLY LEU ASP TYR LEU HIS THR LYS CYS ARG ILE ILE SEQRES 14 A 397 HIS THR ASP ILE LYS PRO GLU ASN ILE LEU LEU SER VAL SEQRES 15 A 397 ASN GLU GLN TYR ILE ARG ARG LEU ALA ALA GLU ALA THR SEQRES 16 A 397 GLU TRP GLN ARG SER GLY ALA PRO PRO PRO SER GLY SER SEQRES 17 A 397 ALA VAL SER THR ALA PRO ALA THR ALA GLY ASN PHE LEU SEQRES 18 A 397 VAL ASN PRO LEU GLU PRO LYS ASN ALA GLU LYS LEU LYS SEQRES 19 A 397 VAL LYS ILE ALA ASP LEU GLY ASN ALA CYS TRP VAL HIS SEQRES 20 A 397 LYS HIS PHE THR GLU ASP ILE GLN THR ARG GLN TYR ARG SEQRES 21 A 397 SER LEU GLU VAL LEU ILE GLY SER GLY TYR ASN THR PRO SEQRES 22 A 397 ALA ASP ILE TRP SER THR ALA CYS MET ALA PHE GLU LEU SEQRES 23 A 397 ALA THR GLY ASP TYR LEU PHE GLU PRO HIS SER GLY GLU SEQRES 24 A 397 GLU TYR THR ARG ASP GLU ASP HIS ILE ALA LEU ILE ILE SEQRES 25 A 397 GLU LEU LEU GLY LYS VAL PRO ARG LYS LEU ILE VAL ALA SEQRES 26 A 397 GLY LYS TYR SER LYS GLU PHE PHE THR LYS LYS GLY ASP SEQRES 27 A 397 LEU LYS HIS ILE THR LYS LEU LYS PRO TRP GLY LEU PHE SEQRES 28 A 397 GLU VAL LEU VAL GLU LYS TYR GLU TRP SER GLN GLU GLU SEQRES 29 A 397 ALA ALA GLY PHE THR ASP PHE LEU LEU PRO MET LEU GLU SEQRES 30 A 397 LEU ILE PRO GLU LYS ARG ALA THR ALA ALA GLU CYS LEU SEQRES 31 A 397 ARG HIS PRO TRP LEU ASN SER SEQRES 1 B 9 ARG ARG ARG GLU ARG SER PRO THR ARG HET ACT A 900 4 HET ADP A 950 27 HETNAM ACT ACETATE ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE FORMUL 3 ACT C2 H3 O2 1- FORMUL 4 ADP C10 H15 N5 O10 P2 HELIX 1 1 ALA A 114 SER A 134 1 21 HELIX 2 2 ASP A 138 MET A 143 5 6 HELIX 3 3 LEU A 172 SER A 179 1 8 HELIX 4 4 PRO A 185 CYS A 207 1 23 HELIX 5 5 LYS A 215 GLU A 217 5 3 HELIX 6 6 ASN A 224 THR A 236 1 13 HELIX 7 7 THR A 514 ARG A 518 5 5 HELIX 8 8 SER A 519 GLY A 525 1 7 HELIX 9 9 THR A 530 GLY A 547 1 18 HELIX 10 10 THR A 560 GLY A 574 1 15 HELIX 11 11 PRO A 577 GLY A 584 1 8 HELIX 12 12 TYR A 586 PHE A 590 5 5 HELIX 13 13 GLY A 607 LYS A 615 1 9 HELIX 14 14 SER A 619 LEU A 631 1 13 HELIX 15 15 PRO A 632 GLU A 635 5 4 HELIX 16 16 THR A 643 ARG A 649 1 7 HELIX 17 17 HIS A 650 SER A 655 5 6 SHEET 1 AA 6 LEU A 75 PHE A 76 0 SHEET 2 AA 6 TYR A 80 TRP A 88 -1 O TYR A 80 N PHE A 76 SHEET 3 AA 6 THR A 93 ASP A 99 -1 O VAL A 94 N LEU A 86 SHEET 4 AA 6 LYS A 104 VAL A 110 -1 O LYS A 104 N ASP A 99 SHEET 5 AA 6 THR A 159 PHE A 165 -1 O MET A 163 N LYS A 109 SHEET 6 AA 6 LEU A 147 SER A 154 -1 N LEU A 148 O VAL A 164 SHEET 1 AB 3 LEU A 168 HIS A 171 0 SHEET 2 AB 3 ILE A 219 SER A 222 -1 O LEU A 221 N GLY A 169 SHEET 3 AB 3 VAL A 493 ILE A 495 -1 O LYS A 494 N LEU A 220 SHEET 1 AC 2 ILE A 209 ILE A 210 0 SHEET 2 AC 2 CYS A 502 TRP A 503 -1 O CYS A 502 N ILE A 210 SITE 1 AC1 2 LYS A 215 GLU A 217 SITE 1 AC2 10 LEU A 86 GLY A 87 TRP A 88 GLY A 89 SITE 2 AC2 10 SER A 92 VAL A 94 ALA A 107 LYS A 109 SITE 3 AC2 10 GLU A 166 LEU A 168 CRYST1 78.680 78.680 310.540 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012710 0.007338 0.000000 0.00000 SCALE2 0.000000 0.014676 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003220 0.00000